The Molecular Biology of Myeloma

David S. Siegel, MD, PhD

Video Categories: Targeted Therapies

Dr. David S. Siegel discusses the importance of understanding the molecular biology of myeloma. Physicians can now look at and offer alternative treatments to patients that they identify will most likely do poorly with traditional treatment. He believes this area will develop quickly over the next 2 to 5 years.
November 24, 2014

Foundation Medicine on a Molecular Level

Dr. Gary Palmer explains how Foundation Medicine is working to improve cancer therapies and personalized medicine on a molecular level.

September 20, 2013

Demonstrating the Value of Personalized Medicine

Jayson Slotnik provides an overview of the issues in demonstrating the value of personalized medicine tests and products